🔸Boehringer Ingelheim covers the entire development process for the global biotechnology industry.
🔸The company excels in upstream processing, which involves culturing animal or microbial cells using controlled feeding, aerating, and process strategies.
🔸They also specialize in downstream processing, which removes contaminants through centrifugation, filtration, and chromatographic technologies.
🔸Boehringer Ingelheim’s expertise also extends to manufacturing, analytical testing, and the business aspects of the biopharmaceutical industry.
🔸Partnerships play a crucial role in helping companies navigate the global business environment of the biopharmaceutical industry.
🔸Overall, Boehringer Ingelheim’s expertise in microbial technology positions them as a leader in the biotechnology industry.
Introduction:
This article discusses Boehringer Ingelheim’s expertise in microbial technology and how the company turns biologic innovation into commercial success. Boehringer Ingelheim is a global pharmaceutical company that specializes in developing and manufacturing biopharmaceutical products. They have a strong focus on microbial technology and use it to generate innovative products with commercial potential.
- Boehringer Ingelheim has extensive experience and expertise in microbial technology, which they use to develop a wide range of biopharmaceutical products. They have optimized their microbial fermentation processes to enhance product yields and improve overall efficiency.
- The company has a robust pipeline of biologic products, including biosimilars and novel therapeutics. They use their microbial technology to develop these products and ensure their quality and safety.
- Boehringer Ingelheim has a strong commitment to patient safety and regulatory compliance. They adhere to stringent quality control measures and follow Good Manufacturing Practices (GMP) to ensure the highest standards of product quality.
- The company also focuses on sustainability and environmental responsibility. They have implemented green biotechnology practices in their manufacturing processes, such as using renewable energy sources and reducing water consumption.
- Boehringer Ingelheim’s expertise in microbial technology has allowed them to establish successful partnerships and collaborations with other biopharmaceutical companies. They provide contract manufacturing services and use their knowledge to assist other companies in developing and manufacturing biologic products.
Conclusion:
Boehringer Ingelheim’s expertise in microbial technology has positioned them as a leader in the biopharmaceutical industry. Their commitment to innovation, quality, and sustainability has enabled them to turn biologic innovation into commercial success. With their extensive experience and partnerships, they continue to contribute to the development of novel biologic products and advance the field of biotechnology.
